• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

交叉反应性记忆 T 细胞与 COVID-19 接触者对 SARS-CoV-2 感染的保护有关。

Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts.

机构信息

NIHR HPRU in Respiratory Infections, Imperial College London, London, England.

National Heart and Lung Institute, Imperial College London, London, England.

出版信息

Nat Commun. 2022 Jan 10;13(1):80. doi: 10.1038/s41467-021-27674-x.

DOI:10.1038/s41467-021-27674-x
PMID:35013199
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8748880/
Abstract

Cross-reactive immune responses to SARS-CoV-2 have been observed in pre-pandemic cohorts and proposed to contribute to host protection. Here we assess 52 COVID-19 household contacts to capture immune responses at the earliest timepoints after SARS-CoV-2 exposure. Using a dual cytokine FLISpot assay on peripheral blood mononuclear cells, we enumerate the frequency of T cells specific for spike, nucleocapsid, membrane, envelope and ORF1 SARS-CoV-2 epitopes that cross-react with human endemic coronaviruses. We observe higher frequencies of cross-reactive (p = 0.0139), and nucleocapsid-specific (p = 0.0355) IL-2-secreting memory T cells in contacts who remained PCR-negative despite exposure (n = 26), when compared with those who convert to PCR-positive (n = 26); no significant difference in the frequency of responses to spike is observed, hinting at a limited protective function of spike-cross-reactive T cells. Our results are thus consistent with pre-existing non-spike cross-reactive memory T cells protecting SARS-CoV-2-naïve contacts from infection, thereby supporting the inclusion of non-spike antigens in second-generation vaccines.

摘要

已在大流行前的队列中观察到针对 SARS-CoV-2 的交叉反应性免疫应答,并提出其有助于宿主保护。在这里,我们评估了 52 例 COVID-19 家庭接触者,以在 SARS-CoV-2 暴露后最早的时间点捕获免疫反应。使用外周血单核细胞的双细胞因子 FLISpot 测定法,我们对针对刺突、核衣壳、膜、包膜和 ORF1 SARS-CoV-2 表位的 T 细胞进行计数,这些表位与人类地方性冠状病毒发生交叉反应。我们观察到,与转 PCR 阳性的接触者(n=26)相比,尽管接触但仍保持 PCR 阴性的接触者(n=26)中,具有交叉反应性(p=0.0139)和核衣壳特异性(p=0.0355)IL-2 分泌记忆 T 细胞的频率更高;而对刺突的反应频率没有显著差异,这暗示了刺突交叉反应性 T 细胞的保护作用有限。因此,我们的结果与预先存在的非刺突交叉反应性记忆 T 细胞保护 SARS-CoV-2 未感染的接触者免受感染的结果一致,从而支持在第二代疫苗中包含非刺突抗原。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceaa/8748880/2077569ff53a/41467_2021_27674_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceaa/8748880/b73d93db55d6/41467_2021_27674_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceaa/8748880/93e1f7d135ff/41467_2021_27674_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceaa/8748880/2077569ff53a/41467_2021_27674_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceaa/8748880/b73d93db55d6/41467_2021_27674_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceaa/8748880/93e1f7d135ff/41467_2021_27674_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceaa/8748880/2077569ff53a/41467_2021_27674_Fig3_HTML.jpg

相似文献

1
Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts.交叉反应性记忆 T 细胞与 COVID-19 接触者对 SARS-CoV-2 感染的保护有关。
Nat Commun. 2022 Jan 10;13(1):80. doi: 10.1038/s41467-021-27674-x.
2
Limited Recognition of Highly Conserved Regions of SARS-CoV-2.有限识别 SARS-CoV-2 的高度保守区域。
Microbiol Spectr. 2022 Feb 23;10(1):e0278021. doi: 10.1128/spectrum.02780-21.
3
Cross-reactive and mono-reactive SARS-CoV-2 CD4+ T cells in prepandemic and COVID-19 convalescent individuals.流行前和 COVID-19 恢复期个体中的交叉反应性和单反应性 SARS-CoV-2 CD4+ T 细胞。
PLoS Pathog. 2021 Dec 29;17(12):e1010203. doi: 10.1371/journal.ppat.1010203. eCollection 2021 Dec.
4
Sequential Analysis of Binding and Neutralizing Antibody in COVID-19 Convalescent Patients at 14 Months After SARS-CoV-2 Infection.新冠病毒感染 14 个月后 COVID-19 恢复期患者结合抗体和中和抗体的动态分析。
Front Immunol. 2021 Nov 26;12:793953. doi: 10.3389/fimmu.2021.793953. eCollection 2021.
5
SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19.SARS-CoV-2 反应性 T 细胞在健康供体和 COVID-19 患者中的研究。
Nature. 2020 Nov;587(7833):270-274. doi: 10.1038/s41586-020-2598-9. Epub 2020 Jul 29.
6
SARS-CoV-2 specific memory T cell epitopes identified in COVID-19-recovered subjects.在 COVID-19 康复者中鉴定出的 SARS-CoV-2 特异性记忆 T 细胞表位。
Virus Res. 2021 Oct 15;304:198508. doi: 10.1016/j.virusres.2021.198508. Epub 2021 Jul 27.
7
Detection of Serum Cross-Reactive Antibodies and Memory Response to SARS-CoV-2 in Prepandemic and Post-COVID-19 Convalescent Samples.检测血清交叉反应抗体和对 SARS-CoV-2 的记忆反应在大流行前和 COVID-19 后恢复期样本中。
J Infect Dis. 2021 Oct 28;224(8):1305-1315. doi: 10.1093/infdis/jiab333.
8
Evidence for increased SARS-CoV-2 susceptibility and COVID-19 severity related to pre-existing immunity to seasonal coronaviruses.与季节性冠状病毒预先存在的免疫有关的 SARS-CoV-2 易感性增加和 COVID-19 严重程度的证据。
Cell Rep. 2021 Dec 28;37(13):110169. doi: 10.1016/j.celrep.2021.110169. Epub 2021 Dec 7.
9
Epitope profiling reveals binding signatures of SARS-CoV-2 immune response in natural infection and cross-reactivity with endemic human CoVs.表位分析揭示了 SARS-CoV-2 自然感染中的免疫反应结合特征,以及与地方性人类冠状病毒的交叉反应性。
Cell Rep. 2021 May 25;35(8):109164. doi: 10.1016/j.celrep.2021.109164. Epub 2021 May 6.
10
Potential Cross-Reactive Immunity to SARS-CoV-2 From Common Human Pathogens and Vaccines.常见人类病原体和疫苗对 SARS-CoV-2 的潜在交叉反应性免疫。
Front Immunol. 2020 Oct 16;11:586984. doi: 10.3389/fimmu.2020.586984. eCollection 2020.

引用本文的文献

1
A Multi-Antigen Broad-Spectrum Coronavirus Vaccine Induces Potent and Durable Cross-Protection Against Infection and Disease Caused by Multiple SARS-CoV-2 Variants.一种多抗原广谱冠状病毒疫苗可诱导针对多种新冠病毒变异株引起的感染和疾病产生强效且持久的交叉保护。
Res Sq. 2025 Aug 20:rs.3.rs-7208748. doi: 10.21203/rs.3.rs-7208748/v1.
2
Immunogenicity of DNA Vaccines against COVID-19 That Encode B- and T-Cell Immunogens after Combined Injection.联合注射后编码B细胞和T细胞免疫原的新型冠状病毒DNA疫苗的免疫原性
Bull Exp Biol Med. 2025 Aug 29. doi: 10.1007/s10517-025-06461-4.
3
Highly conserved Betacoronavirus sequences are broadly recognized by human T cells.

本文引用的文献

1
Detection and quantification of antibody to SARS CoV 2 receptor binding domain provides enhanced sensitivity, specificity and utility.检测和定量 SARS-CoV-2 受体结合域抗体可提高灵敏度、特异性和实用性。
J Virol Methods. 2022 Apr;302:114475. doi: 10.1016/j.jviromet.2022.114475. Epub 2022 Jan 22.
2
Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2.预先存在的聚合酶特异性 T 细胞在 SARS-CoV-2 无血清学阴性中扩增。
Nature. 2022 Jan;601(7891):110-117. doi: 10.1038/s41586-021-04186-8. Epub 2021 Nov 10.
3
Optimized protocol for a quantitative SARS-CoV-2 duplex RT-qPCR assay with internal human sample sufficiency control.
高度保守的β冠状病毒序列被人类T细胞广泛识别。
Cell. 2025 Jul 30. doi: 10.1016/j.cell.2025.07.015.
4
Convalescent plasma therapy and long-term SARS-COV-2 antiviral immune response in a prospective cohort of patients with COVID-19.COVID-19患者前瞻性队列中的恢复期血浆疗法与长期SARS-CoV-2抗病毒免疫反应
Curr Res Microb Sci. 2025 Jul 9;9:100440. doi: 10.1016/j.crmicr.2025.100440. eCollection 2025.
5
Aging and Viral Evolution Impair Immunity Against Dominant Pan-Coronavirus-Reactive T Cell Epitope.衰老和病毒进化削弱针对主要泛冠状病毒反应性T细胞表位的免疫力。
Eur J Immunol. 2025 Jul;55(7):e51888. doi: 10.1002/eji.202551888.
6
Lung-resident SARS-CoV-2 peptide-specific immune responses in perfused 3D human lung explant models.灌注3D人肺外植体模型中肺部驻留的SARS-CoV-2肽特异性免疫反应
Front Bioeng Biotechnol. 2025 Jul 8;13:1587080. doi: 10.3389/fbioe.2025.1587080. eCollection 2025.
7
'Vivaldi': an amplicon-based whole-genome sequencing method for the four seasonal human coronaviruses, 229E, NL63, OC43 and HKU1, alongside SARS-CoV-2.“维瓦尔第”:一种基于扩增子的全基因组测序方法,用于检测四种季节性人类冠状病毒(229E、NL63、OC43和HKU1)以及严重急性呼吸综合征冠状病毒2(SARS-CoV-2)
Microb Genom. 2025 Jul;11(7). doi: 10.1099/mgen.0.001451.
8
Universal Bacterium-Vectored COVID-19 Vaccine Expressing Early SARS-CoV-2 Conserved Proteins Cross-Protects Against Late Variants in Hamsters.表达早期严重急性呼吸综合征冠状病毒2保守蛋白的通用细菌载体新冠疫苗可交叉保护仓鼠免受晚期变异株感染。
Vaccines (Basel). 2025 Jun 12;13(6):633. doi: 10.3390/vaccines13060633.
9
A tentative exploration for the association between influenza virus infection and SARS-CoV-2 infection in Shihezi, China: A test-negative study.中国石河子流感病毒感染与新型冠状病毒感染关联的初步探索:一项检测阴性研究
Infect Dis Model. 2024 Oct 9;10(1):201-206. doi: 10.1016/j.idm.2024.10.002. eCollection 2025 Mar.
10
Early de novo T cell expansion following SARS-CoV-2 infection predicts favourable clinical and virological outcomes.新型冠状病毒2型(SARS-CoV-2)感染后早期的新生T细胞扩增预示着良好的临床和病毒学结果。
EBioMedicine. 2025 Jun 4;117:105795. doi: 10.1016/j.ebiom.2025.105795.
优化的定量 SARS-CoV-2 双重 RT-qPCR 检测方法,具有内部人体样本充足性对照。
J Virol Methods. 2021 Aug;294:114174. doi: 10.1016/j.jviromet.2021.114174. Epub 2021 May 10.
4
Lack of antibodies against seasonal coronavirus OC43 nucleocapsid protein identifies patients at risk of critical COVID-19.缺乏针对季节性冠状病毒 OC43 核衣壳蛋白的抗体可识别出 COVID-19 重症高危患者。
J Clin Virol. 2021 Jun;139:104847. doi: 10.1016/j.jcv.2021.104847. Epub 2021 Apr 24.
5
CD8 T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity.针对 SARS-CoV-2 核衣壳表位具有特异性的 CD8 T 细胞表现出高的初始前体频率和 TCR 多样性。
Immunity. 2021 May 11;54(5):1066-1082.e5. doi: 10.1016/j.immuni.2021.04.009. Epub 2021 Apr 15.
6
CD8 T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses.针对 SARS-CoV-2 核衣壳表位的免疫优势 CD8 T 细胞与选择性季节性冠状病毒发生交叉反应。
Immunity. 2021 May 11;54(5):1055-1065.e5. doi: 10.1016/j.immuni.2021.04.006. Epub 2021 Apr 13.
7
Designing a SARS-CoV-2 T-Cell-Inducing Vaccine for High-Risk Patient Groups.为高风险患者群体设计一种诱导SARS-CoV-2 T细胞的疫苗。
Vaccines (Basel). 2021 Apr 24;9(5):428. doi: 10.3390/vaccines9050428.
8
A human coronavirus evolves antigenically to escape antibody immunity.一种人类冠状病毒会通过抗原进化来逃避抗体免疫。
PLoS Pathog. 2021 Apr 8;17(4):e1009453. doi: 10.1371/journal.ppat.1009453. eCollection 2021 Apr.
9
T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses.T 细胞检测可区分临床和亚临床 SARS-CoV-2 感染与交叉反应性抗病毒反应。
Nat Commun. 2021 Apr 6;12(1):2055. doi: 10.1038/s41467-021-21856-3.
10
Genomic characterization of a novel SARS-CoV-2 lineage from Rio de Janeiro, Brazil.来自巴西里约热内卢的新型严重急性呼吸综合征冠状病毒2(SARS-CoV-2)谱系的基因组特征分析
J Virol. 2021 Apr 26;95(10). doi: 10.1128/JVI.00119-21. Epub 2021 Mar 1.